Action 8037 CHINA BIOTECH SERVICES HOLDINGS LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues China Biotech Services Holdings Limited Hong Kong S.E.

Actions

8037

BMG7713H1575

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
China Biotech Services Holdings Limited Announces Not Recommends Final Dividend for the Year Ended 31 December 2023
China Biotech Services Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
China Biotech Services Holdings Limited announced that it expects to receive HKD 88 million in funding
China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
Pengbo Medical Technology Co., Ltd. Announces the Approval by the Hainan Provincial Medical Products Administration for the Import of Medical Devices
China Biotech Services Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
China Biotech Services Holdings Limited Provides Group Earnings Guidance for the Nine Months Ended September 30, 2023
China Biotech Services Holdings Limited Announces Strategic Cooperation Framework Agreement with Astrazeneca Investment Co., Ltd
China Biotech Services Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
China Biotech Services Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023
China Biotech Services Holdings Limited Announces Redesignation of Chui Hoi Yam from an Executive Director to Non-Executive Director
China Biotech Services Holdings Limited Declares Final Dividend for the Year Ended 31 December 2022
China Biotech Services Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
China Biotech Services Holdings Limited and The Chinese University of Hong Kong Enter into Memorandum of Understanding
China Biotech Services Holdings Limited Provides Group Earnings Guidance for the Three Months Ended 31 March 2023
China Biotech Services Holdings Limited Proposes Final Ordinary Dividend for the Year Ended December 31, 2022, Payable on 15 June 2023
China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2022
China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC 2022 and receives CAP Accreditation Certificate
China Biotech Services Holdings Limited announced that it has received HKD 77.8 million in funding from Guoyuan Securities Investment (Hong Kong) Limited
China Biotech Services Holdings Limited Announces Board Changes
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 8037
  4. Action 8037
  5. Actualités China Biotech Services Holdings Limited
  6. Autres langues